Expression of the Antiapoptotic Gene Seladin-1 and Octreotide-Induced Apoptosis in Growth Hormone-Secreting and Nonfunctioning Pituitary Adenomas
Author(s) -
Paola Luciani,
Stefania Gelmini,
Emanuele Ferrante,
Andrea Lania,
Susanna Benvenuti,
Silvana Baglioni,
Giovanna Mantovani,
Ilaria Cellai,
Franco Ammannati,
Anna Spada,
Mario Serio,
Alessandro Peri
Publication year - 2005
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2005-0633
Subject(s) - medicine , endocrinology , apoptosis , pituitary adenoma , pituitary gland , somatostatin , context (archaeology) , pituitary neoplasm , biology , gene expression , adenoma , cancer research , hormone , gene , genetics , paleontology
Seladin-1 (from selective Alzheimer's disease indicator-1) is a recently discovered gene that has been found to be down-regulated in brain regions affected by Alzheimer's disease. Seladin-1 effectively protects neurons against beta-amyloid-mediated toxicity and prevents apoptosis via inhibition of the activation of caspase-3, a key mediator of the apoptotic cascade. Although seladin-1 is expressed in the pituitary gland, no study addressed the expression or the function of this gene in pituitary adenomas.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom